Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6VDF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,841
Award facts
- Contract value 100% obligated
- $11,841.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $11,841.34 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on January 15, 2026, for the supply of Dupixent 300 mg/2 mL pen injectors (2 mL). The contract, which carries an ultimate completion date of January 16, 2026, represents a non-set-aside award made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's parent company Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally. Dupixent (dupilumab) is a biologic immunosuppressant used to treat various allergic and inflammatory conditions, and this procurement supports the Defense Health Agency and other federal healthcare systems' pharmaceutical inventory requirements.
Quick answers
Who was awarded contract SPE2DR26F6VDF?
SPE2DR26F6VDF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F6VDF worth?
The government has obligated $11,841 on SPE2DR26F6VDF.
Is contract SPE2DR26F6VDF an order under another contract?
Yes. SPE2DR26F6VDF is a delivery order under SPE2DR25D3802, an indefinite delivery contract.
Was contract SPE2DR26F6VDF competed?
The extent of competition for SPE2DR26F6VDF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award